1. Home
  2. FATE vs SKIL Comparison

FATE vs SKIL Comparison

Compare FATE & SKIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FATE
  • SKIL
  • Stock Information
  • Founded
  • FATE 2007
  • SKIL 1998
  • Country
  • FATE United States
  • SKIL United States
  • Employees
  • FATE N/A
  • SKIL N/A
  • Industry
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • SKIL Computer Software: Prepackaged Software
  • Sector
  • FATE Health Care
  • SKIL Technology
  • Exchange
  • FATE Nasdaq
  • SKIL Nasdaq
  • Market Cap
  • FATE 125.7M
  • SKIL 123.2M
  • IPO Year
  • FATE 2013
  • SKIL N/A
  • Fundamental
  • Price
  • FATE $1.15
  • SKIL $15.20
  • Analyst Decision
  • FATE Hold
  • SKIL
  • Analyst Count
  • FATE 7
  • SKIL 0
  • Target Price
  • FATE $3.58
  • SKIL N/A
  • AVG Volume (30 Days)
  • FATE 1.5M
  • SKIL 30.3K
  • Earning Date
  • FATE 08-12-2025
  • SKIL 09-08-2025
  • Dividend Yield
  • FATE N/A
  • SKIL N/A
  • EPS Growth
  • FATE N/A
  • SKIL N/A
  • EPS
  • FATE N/A
  • SKIL N/A
  • Revenue
  • FATE $8,470,000.00
  • SKIL $527,402,000.00
  • Revenue This Year
  • FATE N/A
  • SKIL $3.18
  • Revenue Next Year
  • FATE N/A
  • SKIL $2.50
  • P/E Ratio
  • FATE N/A
  • SKIL N/A
  • Revenue Growth
  • FATE N/A
  • SKIL N/A
  • 52 Week Low
  • FATE $0.66
  • SKIL $11.01
  • 52 Week High
  • FATE $4.20
  • SKIL $34.43
  • Technical
  • Relative Strength Index (RSI)
  • FATE 53.09
  • SKIL 52.98
  • Support Level
  • FATE $1.06
  • SKIL $14.30
  • Resistance Level
  • FATE $1.18
  • SKIL $15.21
  • Average True Range (ATR)
  • FATE 0.09
  • SKIL 0.67
  • MACD
  • FATE 0.02
  • SKIL 0.14
  • Stochastic Oscillator
  • FATE 72.73
  • SKIL 69.38

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About SKIL Skillsoft Corp.

Skillsoft Corp is a leader in corporate digital learning. The company's segment includes Talent Development Solutions and Global Knowledge. Talent Development Solutions brings a foundation of products and customers. TDS enterprise-grade solution serves customers and employees world-wide. TDS Learner is a world-renowned consumer-scale and experience learner platform that serves learners world-wide. The Global Knowledge segment is centered around instructor-led training, or live learning, with face-to-face delivery by experienced trainers, both in-person and virtually.

Share on Social Networks: